Daxor Corporation (DXR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Daxor Corporation (DXR) has a cash flow conversion efficiency ratio of 0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($467.04K) by net assets ($35.63 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Daxor Corporation to measure how much of total assets are equity-financed.
Daxor Corporation - Cash Flow Conversion Efficiency Trend (1985–2024)
This chart illustrates how Daxor Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Daxor Corporation to evaluate the quality of earnings relative to operating cash generation.
Daxor Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Daxor Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Korea Cable T.V Chung-Buk System Co. Ltd.
KQ:066790
|
-0.007x |
|
Infas Holding AG
F:IFS
|
-2.367x |
|
Altinyag Kombinalari AS
IS:ALMAD
|
0.013x |
|
Cato Corporation
NYSE:CATO
|
0.048x |
|
Plastikkart Akilli Kart Iletisim Sistemleri Sanayi ve Ticaret AS
IS:PKART
|
0.157x |
|
Redtone International Bhd
KLSE:0032
|
-0.013x |
|
Seafire AB
ST:SEAF
|
0.002x |
|
Pinetree Capital Ltd
TO:PNP
|
-0.040x |
Annual Cash Flow Conversion Efficiency for Daxor Corporation (1985–2024)
The table below shows the annual cash flow conversion efficiency of Daxor Corporation from 1985 to 2024. For the full company profile with market capitalisation and key ratios, see DXR market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $35.79 Million | $25.69K | 0.001x | +100.67% |
| 2023-12-31 | $34.01 Million | $-3.66 Million | -0.107x | -304.70% |
| 2022-12-31 | $28.97 Million | $-769.30K | -0.027x | +79.64% |
| 2021-12-31 | $21.15 Million | $-2.76 Million | -0.130x | +16.47% |
| 2020-12-31 | $15.68 Million | $-2.45 Million | -0.156x | -164.05% |
| 2019-12-31 | $12.77 Million | $3.11 Million | 0.244x | +342.04% |
| 2018-12-31 | $13.06 Million | $-1.32 Million | -0.101x | -18.18% |
| 2017-12-31 | $13.76 Million | $-1.17 Million | -0.085x | -182.11% |
| 2016-12-31 | $15.34 Million | $1.59 Million | 0.104x | -91.92% |
| 2015-12-31 | $14.43 Million | $18.53 Million | 1.284x | +10776.23% |
| 2014-12-31 | $24.58 Million | $-295.64K | -0.012x | +96.49% |
| 2013-12-31 | $26.37 Million | $-9.04 Million | -0.343x | -368.80% |
| 2012-12-31 | $35.11 Million | $4.48 Million | 0.128x | +170.98% |
| 2011-12-31 | $36.22 Million | $-6.51 Million | -0.180x | -48.43% |
| 2010-12-31 | $47.00 Million | $-5.69 Million | -0.121x | -9.77% |
| 2009-12-31 | $47.63 Million | $-5.25 Million | -0.110x | -18.67% |
| 2008-12-31 | $43.46 Million | $-4.04 Million | -0.093x | -62.40% |
| 2007-12-31 | $54.92 Million | $-3.14 Million | -0.057x | +24.08% |
| 2006-12-31 | $45.64 Million | $-3.44 Million | -0.075x | -152.57% |
| 2005-12-31 | $38.74 Million | $-1.16 Million | -0.030x | +34.97% |
| 2004-12-31 | $39.88 Million | $-1.83 Million | -0.046x | -51.31% |
| 2003-12-31 | $36.42 Million | $-1.10 Million | -0.030x | -378.23% |
| 2002-12-31 | $33.55 Million | $-212.77K | -0.006x | -201.10% |
| 2001-12-31 | $35.33 Million | $221.63K | 0.006x | +327.81% |
| 2000-12-31 | $38.67 Million | $-106.49K | -0.003x | +82.89% |
| 1999-12-31 | $29.28 Million | $-471.20K | -0.016x | +28.99% |
| 1998-12-31 | $35.30 Million | $-800.00K | -0.023x | -286.40% |
| 1997-12-31 | $32.90 Million | $400.00K | 0.012x | +93.31% |
| 1996-12-31 | $31.80 Million | $200.00K | 0.006x | -32.70% |
| 1995-12-31 | $32.10 Million | $300.00K | 0.009x | -70.93% |
| 1994-12-31 | $31.10 Million | $1.00 Million | 0.032x | -39.65% |
| 1993-12-31 | $24.40 Million | $1.30 Million | 0.053x | -48.34% |
| 1992-12-31 | $22.30 Million | $2.30 Million | 0.103x | +64.16% |
| 1991-12-31 | $19.10 Million | $1.20 Million | 0.063x | -42.64% |
| 1990-12-31 | $21.00 Million | $2.30 Million | 0.110x | +509.62% |
| 1989-12-31 | $18.70 Million | $-500.00K | -0.027x | -114.94% |
| 1988-12-31 | $19.00 Million | $3.40 Million | 0.179x | +59.93% |
| 1986-12-31 | $14.30 Million | $1.60 Million | 0.112x | -19.81% |
| 1985-12-31 | $12.90 Million | $1.80 Million | 0.140x | -- |
About Daxor Corporation
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corpo… Read more